However, the likely beneficiaries aren't limited to the likes of Pfizer and AstraZeneca, and it is worth noting that these companies have already established numerous agreements with ASX listed healthcare and biotech companies, including some of the ...
>>>Related articles:
http://finfeed.com/biotech/pfizer-deal-brings-cancer-companies-spotlight/20160824/
However, the likely beneficiaries aren't limited to the likes of...
Add to My Watchlist
What is My Watchlist?